Key takeaways from that interview:
-More petri dish results to follow soon.
-Future patents filings based on petri dish results.
-Cancer focus will be with Esophageal cancer.
-Animal study will start next month.
-Results expected mid Jan - early February.
-Pre IND package after that
-Should be a quicker process for an FDA meeting since they already have that process in place for their covid/cepharanthine pill project.
Recent LMLLF News
- Specialty Pharma Company Moving Higher After Signing LOI for Pharmaceutical-Grade Cocaine • AllPennyStocks.com • 05/23/2024 04:34:00 PM
FEATURED Animoca Brands leads Hivello funding round ahead of Token Listing • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM
VAYK Project $700K 2024 Revenue with $150K Net Profit • VAYK • Feb 5, 2025 12:43 PM
UAV Corp (UMAV) Kicks Off Landmark "SKY" Hangar Project with Land Clearing at Costin Airport Setting Stage for Q1 2025 Groundbreaking • UMAV • Feb 5, 2025 8:30 AM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM